Robert Deresiewicz will give up his comanager role on Hartford Healthcare in June 2022 and retire from subadvisor Wellington Management Company. Deresiewicz, who has served as a comanager since 2000, is seasoned as well as skilled, so he will be missed. But his departure is roughly 11 months away. Long-serving comanager Ann Gallo and comanager Rebecca Sykes remain in place, and they are experienced and talented healthcare investors themselves. Meanwhile, Wen Shi was just promoted to comanager on the fund after roughly six years as an analyst; he has 14 years of healthcare investment and related experience overall; and he, like Deresiewicz, is a biotechnology specialist. The managers continue to be supported by a solid set of healthcare analysts. And the fund’s other strengths are still intact. For all these reasons, the fund remains an attractive source of healthcare exposure, and its People Pillar rating, Process Pillar rating, and Morningstar Analyst Ratings are unchanged.
Will HGHCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
The Process Pillar is our assessment of how sensible, clearly defined, and repeatable HGHCX’s performance objective and investment process is for both security selection and portfolio construction.
The People Pillar is our evaluation of the HGHCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
The Parent Pillar is our rating of HGHCX’s parent organization’s priorities and whether they’re in line with investors’ interests.